These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Therapy of hypertension. A new rapidly effective AT1 blocker]. MMW Fortschr Med; 2002 Jun; 144(25):55. PubMed ID: 12136675 [No Abstract] [Full Text] [Related]
3. [Therapy of hypertension. AT1 blockers soon to be the first choice?]. MMW Fortschr Med; 2002 May; 144(19):64. PubMed ID: 12116560 [No Abstract] [Full Text] [Related]
4. Medical and cost-economy aspects of modern antihypertensive therapy--with special reference to 2 years of clinical experience with losartan. Hansson L Blood Press Suppl; 1997; 1():52-5. PubMed ID: 9285110 [TBL] [Abstract][Full Text] [Related]
5. [Changed guidelines of the German High Blood Pressure League. AT(1) blocker in the first league now]. MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494603 [No Abstract] [Full Text] [Related]
6. [AT1 blocker therapy of hypertension in seniors. Added protection for cerebral blood vessels?]. MMW Fortschr Med; 2003 Jan; 145(1-2):53. PubMed ID: 12638442 [No Abstract] [Full Text] [Related]
7. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade? Brunner HR J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462 [No Abstract] [Full Text] [Related]
8. Angiotensin-receptor blocker approved as antihypertensive. Am J Health Syst Pharm; 1995 Jul; 52(13):1368, 1373. PubMed ID: 7671033 [No Abstract] [Full Text] [Related]
10. New angiotensin-II blocker. Lilley LL; Guanci R Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540 [No Abstract] [Full Text] [Related]
11. A new antihypertensive class: the angiotensin receptor antagonist. Kupecz D Nurse Pract; 1996 Mar; 21(3):106, 109, 113-4. PubMed ID: 8710244 [No Abstract] [Full Text] [Related]
12. Tribenzor for hypertension. Med Lett Drugs Ther; 2010 Sep; 52(1346):70-1. PubMed ID: 20814402 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II antagonism: a new avenue of hypertension management. Gavras H Blood Press Suppl; 1997; 1():42-6. PubMed ID: 9285108 [TBL] [Abstract][Full Text] [Related]
14. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension. Lacourcière Y Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218 [TBL] [Abstract][Full Text] [Related]
15. [Angiotensin receptor antagonists. A new class of antihypertensive agents]. Mann J Dtsch Med Wochenschr; 1996 Apr; 121(17):568-71. PubMed ID: 8620827 [No Abstract] [Full Text] [Related]
17. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension. Kato J; Yokota N; Tamaki N; Kariya S; Kita T; Ayabe T; Eto T; Kitamura K Hypertens Res; 2011 Mar; 34(3):331-5. PubMed ID: 21124326 [TBL] [Abstract][Full Text] [Related]
18. [Angiotensin II receptor antagonists in arterial hypertension: new clinical evidence with candesartan]. Mancia G; Turri C; Magnoni M; Grassi G Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):439-42. PubMed ID: 12497948 [No Abstract] [Full Text] [Related]
19. Angiotensin receptor blockers and diuretics as combination therapy: clinical implications. Ram CV Am J Hypertens; 2004 Mar; 17(3):277-80. PubMed ID: 15001204 [No Abstract] [Full Text] [Related]
20. [Losartan and the LIFE-study. Antihypertensive treatment with AT1-receptor antagonist]. Kjeldsen SE; Omvik P Tidsskr Nor Laegeforen; 1996 Feb; 116(4):504-7. PubMed ID: 8644056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]